Statement Of Changes In Equity [Abstract]

Medistim - Filing #2616472

Concept As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
27,000 NOK
240 160 NOK
6 138 NOK
13 344 NOK
306 052 NOK
246 298 NOK
59 754 NOK
41 852 NOK
4 585 NOK
203 899 NOK
204 680 NOK
52 165 NOK
5 762 NOK
4 585 NOK
33,000 NOK
781,000 NOK
41 852 NOK
256 846 NOK
1 746 NOK
4 330 NOK
236 861 NOK
41 852 NOK
184 384 NOK
50 730 NOK
186 130 NOK
36,000 NOK
4 585 NOK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
90 900 NOK
69 387 NOK
Comprehensive income
96 257 NOK
- NOK
- NOK
5 357 NOK
- NOK
- NOK
- NOK
96 257 NOK
90 900 NOK
68 422 NOK
- NOK
69 387 NOK
68 422 NOK
- NOK
965,000 NOK
- NOK
- NOK
- NOK
Dividends recognised as distributions to owners
54 640 NOK
- NOK
- NOK
- NOK
- NOK
- NOK
- NOK
54 640 NOK
54 640 NOK
50 052 NOK
- NOK
50 052 NOK
50 052 NOK
- NOK
- NOK
- NOK
- NOK
- NOK
Increase (decrease) through share-based payment transactions, equity
- NOK
7 589 NOK
6,000 NOK
- NOK
- NOK
- NOK
7 582 NOK
7 589 NOK
- NOK
1 615 NOK
3,000 NOK
180,000 NOK
180,000 NOK
1 435 NOK
- NOK
1 432 NOK
- NOK
- NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.